Is speed of healing a good predictor of eventual healing of pyoderma gangrenosum?

United Kingdom Dermatology Clinical Trials Network STOP GAP team

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background Pyoderma gangrenosum is a rare inflammatory skin condition. Two prospective studies have evaluated treatments for pyoderma gangrenosum using a primary outcome of healing speed at 6 weeks. Objective Using data from both studies we assessed the predictive value of 3 early predictors for healing at 6 months: speed of healing, Investigator Global Assessment (IGA), and resolution of inflammation, recorded at 2 and 6 weeks. Methods Logistic regression models were applied and the effectiveness of the 3 measures was assessed through estimating the positive and negative predictive values and the area under the receiver operating characteristic curve. Results The positive and negative predictive value at 6 weeks were, respectively, 63.5% (95% confidence interval [CI] 52.4%-73.7%) and 74.6% (95% CI 62.5%-84.5%) for speed of healing; 80% (95% CI 68.7%-88.6%) and 74.2% (95% CI 64.1%-82.7%) for IGA; and 72.1% (95% CI 59.9%-82.3%) and 68.1% (95% CI 57.7%-77.3%) for resolution of inflammation. IGA had the best combined positive predictive value, negative predictive value, and area under the receiver operating characteristic curve at 2 and 6 weeks. Limitations We were limited by data available from existing datasets. Conclusion Speed of healing, IGA, and resolution of inflammation were all shown to be good predictors of eventual healing of pyoderma gangrenosum.

Original languageEnglish
Pages (from-to)1216-1220.e2
Number of pages5
JournalJournal of the American Academy of Dermatology
Volume75
Issue number6
Early online date11 Oct 2016
DOIs
Publication statusPublished - 1 Dec 2016

Fingerprint

Pyoderma Gangrenosum
Confidence Intervals
Research Personnel
Inflammation
ROC Curve
Logistic Models
Prospective Studies
Skin

Keywords

  • clinical practice
  • clinical trials
  • lesion improvement
  • predictors
  • pyoderma gangrenosum
  • resolution of inflammation
  • speed of healing

ASJC Scopus subject areas

  • Dermatology

Cite this

Is speed of healing a good predictor of eventual healing of pyoderma gangrenosum? / United Kingdom Dermatology Clinical Trials Network STOP GAP team.

In: Journal of the American Academy of Dermatology, Vol. 75, No. 6, 01.12.2016, p. 1216-1220.e2.

Research output: Contribution to journalArticle

United Kingdom Dermatology Clinical Trials Network STOP GAP team. / Is speed of healing a good predictor of eventual healing of pyoderma gangrenosum?. In: Journal of the American Academy of Dermatology. 2016 ; Vol. 75, No. 6. pp. 1216-1220.e2.
@article{e2af0a3493ca4dc88288f02029ed3162,
title = "Is speed of healing a good predictor of eventual healing of pyoderma gangrenosum?",
abstract = "Background Pyoderma gangrenosum is a rare inflammatory skin condition. Two prospective studies have evaluated treatments for pyoderma gangrenosum using a primary outcome of healing speed at 6 weeks. Objective Using data from both studies we assessed the predictive value of 3 early predictors for healing at 6 months: speed of healing, Investigator Global Assessment (IGA), and resolution of inflammation, recorded at 2 and 6 weeks. Methods Logistic regression models were applied and the effectiveness of the 3 measures was assessed through estimating the positive and negative predictive values and the area under the receiver operating characteristic curve. Results The positive and negative predictive value at 6 weeks were, respectively, 63.5{\%} (95{\%} confidence interval [CI] 52.4{\%}-73.7{\%}) and 74.6{\%} (95{\%} CI 62.5{\%}-84.5{\%}) for speed of healing; 80{\%} (95{\%} CI 68.7{\%}-88.6{\%}) and 74.2{\%} (95{\%} CI 64.1{\%}-82.7{\%}) for IGA; and 72.1{\%} (95{\%} CI 59.9{\%}-82.3{\%}) and 68.1{\%} (95{\%} CI 57.7{\%}-77.3{\%}) for resolution of inflammation. IGA had the best combined positive predictive value, negative predictive value, and area under the receiver operating characteristic curve at 2 and 6 weeks. Limitations We were limited by data available from existing datasets. Conclusion Speed of healing, IGA, and resolution of inflammation were all shown to be good predictors of eventual healing of pyoderma gangrenosum.",
keywords = "clinical practice, clinical trials, lesion improvement, predictors, pyoderma gangrenosum, resolution of inflammation, speed of healing",
author = "Wilkes, {Sally R.} and Williams, {Hywel C.} and Ormerod, {Anthony D.} and Craig, {Fiona E.} and Nicola Greenlaw and John Norrie and Mitchell, {Eleanor J.} and Mason, {James M.} and Thomas, {Kim S.} and {United Kingdom Dermatology Clinical Trials Network STOP GAP team}",
year = "2016",
month = "12",
day = "1",
doi = "10.1016/j.jaad.2016.07.049",
language = "English",
volume = "75",
pages = "1216--1220.e2",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - Is speed of healing a good predictor of eventual healing of pyoderma gangrenosum?

AU - Wilkes, Sally R.

AU - Williams, Hywel C.

AU - Ormerod, Anthony D.

AU - Craig, Fiona E.

AU - Greenlaw, Nicola

AU - Norrie, John

AU - Mitchell, Eleanor J.

AU - Mason, James M.

AU - Thomas, Kim S.

AU - United Kingdom Dermatology Clinical Trials Network STOP GAP team

PY - 2016/12/1

Y1 - 2016/12/1

N2 - Background Pyoderma gangrenosum is a rare inflammatory skin condition. Two prospective studies have evaluated treatments for pyoderma gangrenosum using a primary outcome of healing speed at 6 weeks. Objective Using data from both studies we assessed the predictive value of 3 early predictors for healing at 6 months: speed of healing, Investigator Global Assessment (IGA), and resolution of inflammation, recorded at 2 and 6 weeks. Methods Logistic regression models were applied and the effectiveness of the 3 measures was assessed through estimating the positive and negative predictive values and the area under the receiver operating characteristic curve. Results The positive and negative predictive value at 6 weeks were, respectively, 63.5% (95% confidence interval [CI] 52.4%-73.7%) and 74.6% (95% CI 62.5%-84.5%) for speed of healing; 80% (95% CI 68.7%-88.6%) and 74.2% (95% CI 64.1%-82.7%) for IGA; and 72.1% (95% CI 59.9%-82.3%) and 68.1% (95% CI 57.7%-77.3%) for resolution of inflammation. IGA had the best combined positive predictive value, negative predictive value, and area under the receiver operating characteristic curve at 2 and 6 weeks. Limitations We were limited by data available from existing datasets. Conclusion Speed of healing, IGA, and resolution of inflammation were all shown to be good predictors of eventual healing of pyoderma gangrenosum.

AB - Background Pyoderma gangrenosum is a rare inflammatory skin condition. Two prospective studies have evaluated treatments for pyoderma gangrenosum using a primary outcome of healing speed at 6 weeks. Objective Using data from both studies we assessed the predictive value of 3 early predictors for healing at 6 months: speed of healing, Investigator Global Assessment (IGA), and resolution of inflammation, recorded at 2 and 6 weeks. Methods Logistic regression models were applied and the effectiveness of the 3 measures was assessed through estimating the positive and negative predictive values and the area under the receiver operating characteristic curve. Results The positive and negative predictive value at 6 weeks were, respectively, 63.5% (95% confidence interval [CI] 52.4%-73.7%) and 74.6% (95% CI 62.5%-84.5%) for speed of healing; 80% (95% CI 68.7%-88.6%) and 74.2% (95% CI 64.1%-82.7%) for IGA; and 72.1% (95% CI 59.9%-82.3%) and 68.1% (95% CI 57.7%-77.3%) for resolution of inflammation. IGA had the best combined positive predictive value, negative predictive value, and area under the receiver operating characteristic curve at 2 and 6 weeks. Limitations We were limited by data available from existing datasets. Conclusion Speed of healing, IGA, and resolution of inflammation were all shown to be good predictors of eventual healing of pyoderma gangrenosum.

KW - clinical practice

KW - clinical trials

KW - lesion improvement

KW - predictors

KW - pyoderma gangrenosum

KW - resolution of inflammation

KW - speed of healing

UR - http://www.scopus.com/inward/record.url?scp=84996551521&partnerID=8YFLogxK

U2 - 10.1016/j.jaad.2016.07.049

DO - 10.1016/j.jaad.2016.07.049

M3 - Article

VL - 75

SP - 1216-1220.e2

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

SN - 0190-9622

IS - 6

ER -